Neurogene Inc.
NGNE
$15.22
-$0.29-1.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 15.72% | -5.76% | |||
| Gross Profit | -15.72% | 5.76% | |||
| SG&A Expenses | 32.34% | 4.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.49% | -3.01% | |||
| Operating Income | -20.49% | 3.01% | |||
| Income Before Tax | -16.06% | 3.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -16.06% | 3.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -16.06% | 3.48% | |||
| EBIT | -20.49% | 3.01% | |||
| EBITDA | -21.45% | 3.08% | |||
| EPS Basic | -7.61% | 15.95% | |||
| Normalized Basic EPS | -7.61% | 15.95% | |||
| EPS Diluted | -7.38% | 15.77% | |||
| Normalized Diluted EPS | -7.61% | 15.95% | |||
| Average Basic Shares Outstanding | 7.84% | 14.84% | |||
| Average Diluted Shares Outstanding | 7.84% | 14.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||